Inherited cardiomyopathies mimicking arrhythmogenic right ventricular cardiomyopathy
Arrhythmia Research Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology (Impact Factor: 2). 08/2009; 19(5):316-20. DOI: 10.1016/j.carpath.2009.06.003
Arrhythmogenic right ventricular cardiomyopathy (ARVC) represents an inherited cardiomyopathy that manifests clinically with malignant ventricular arrhythmias, sudden cardiac death, and less commonly heart failure. The condition is characterized by replacement of the myocardium, primarily of the right ventricle, with fibrofatty tissue. Extensive fibrofatty replacement of the myocardium has been previously thought to be pathognomonic of ARVC; however, this report details two other forms of inherited cardiomyopathy, namely hypertrophic cardiomyopathy (HCM) and the PRKAG2 cardiac syndrome, that were found to have significant fibrofatty myocardial replacement at pathologic examination. This report represents the first documentation of inherited cardiomyopathies mimicking ARVC and highlights the concept that other cardiac conditions can be associated with fibrofatty replacement of the myocardium.
- [Show abstract] [Hide abstract]
ABSTRACT: We describe the case of a 54-year-old man who presented with cardiac sarcoid 1 month after tapering of corticosteroids and 3 years post-cardiac transplantation. In addition to evidence of noncaseating granulomas on endomyocardial biopsy, a cardiac magnetic resonance imaging (MRI) study showed a typical subepicardial pattern of fibrosis corroborating the pathological diagnosis of sarcoid. This is the first description of cardiac sarcoid developing so late after transplantation. This report suggests that MRI may be an effective noninvasive modality to identify sarcoid in cardiac allografts.Transplantation Proceedings 06/2010; 42(5):1976-8. DOI:10.1016/j.transproceed.2010.01.066 · 0.98 Impact Factor
- Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology 12/2010; 20(6):387-8. DOI:10.1016/j.carpath.2010.11.002 · 2.00 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: The era of gene discovery and molecular medicine has had a significant impact on clinical practice. Knowledge of specific genetic findings causative for or associated with human disease may enhance diagnostic accuracy and influence treatment decisions. In cardiovascular disease, gene discovery for inherited arrhythmia syndromes has advanced most rapidly. The arrhythmia specialist is often confronted with the challenge of diagnosing and managing genetic arrhythmia syndromes. There is now a clear need for guidelines on the appropriate use of genetic testing for the most common genetic conditions associated with a risk of sudden cardiac death. This document represents the first ever published recommendations outlining the role of genetic testing in various clinical scenarios, the specific genes to be considered for testing, and the utility of test results in the management of patients and their families.The Canadian journal of cardiology 03/2011; 27(2):232-45. DOI:10.1016/j.cjca.2010.12.078 · 3.94 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.